Late Breaking Clinical Trials & First Report Investigations
On Demand

Presented at the 29th Annual International AF Symposium February 2024

Late Breaking Clinical Science Session I


Moderators: Angelo Auricchio, MD, PhD and Kalyanam Shivkumar, MD, PhD
All talks 10 minutes & 5 minutes Q&A

Acute Kidney Injury Resulting From Hemoglobinuria Following Pulsed-Field Ablation In Atrial Fibrillation: Is It Preventable?
Andrea Natale, MD

Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation
Jose Osorio, MD

Impact of Left Atrial Posterior Wall Ablation During Pulsed Field Ablation for Persistent Atrial Fibrillation: A MANIFEST-PF Registry
Sub-Study
Mohit Turagam, MD

Safety, Efficiency, and Accuracy of Pre-procedural Predictive Modeling Using Artificial Intelligence Algorithm to Predict the Left Atrial Appendage Characteristics and the Appropriate Device Size for Closure
Devi Nair, MD

Late Breaking Clinical Science Session II

Moderators: Kalyanam Shivkumar, MD, PhD and Angelo Auricchio, MD, PhD
All talks 10 minutes & 5 minutes Q&A

First Experience with the Amulet Occluder in the United States: Early Insights from EMERGE LAA Post-Approval Study
Christopher R. Ellis, MD

Pulmonary Vein Narrowing after Pulsed Field vs Thermal Ablation: A Prespecified Secondary Endpoint of the Randomized ADVENT Trial
Moussa Mansour, MD

Pulsed Field Ablation Using a Variable Loop Circular Catheter with 3D Mapping Integration: Early Outcomes of the admIRE Study
David Newton, MD

Predictors of Success for Pulmonary Vein Isolation with Pulsed Field Ablation Using a Variable Loop Catheter with 3D Mapping Integration: Complete 12-month outcomes from inspire
Vivek Reddy, MD

Long-Term Effects of Pulsed Field Ablation on Coronary Arteries
Yury Malyshev, MD

Left Atrial Appendage Exclusion in Addition to Pulmonary Vein Isolation for 
Non-paroxysmal Atrial Fibrillation: Results from the aMAZE Continued Access Protocol (aMAZE CAP)
Dhanunjaya Lakkireddy, MD, MBA